Huixiao Hong received his PhD at Nanjing University China in 1990 and completed his postdoctoral fellowship at the Maxwell Institute at Leeds University in UK. He was an Associate Professor at Nanjing University from 1992 to 1995 where he investigated computerassisted molecular design. From 1995 to 1998 he worked at National Cancer Institute at National Institutes of Health as a Visiting Scientist. He discovered and designed more than 60 potent HIV integrase inhibitors and cyclooxygenase COX inhibitors. He also identified a mononucleotidebinding site in HIV integrase and elucidated the stereoselective binding mode of ibuprofen in COX1. From 1998 to 2000 he held a Research Scientist position in Sumitomo Chemical Company in Japan. He joined the information technology and scientific computing contract under ZTech at FDA’s NCTR in 2000 and served as the computational science group manager from 2002 to 2007. He became a senior scientist at the US FDA’s National Center for Toxicological Research in 2007. He published more than 80 scientific papers and served as an Executive Editor or a member of Editorial Board of 9 peerreviewed journals and as a reviewer of more than 20 peerreviewed journals in the area of pharmacogenomics proteomics bioinformatics and chemoinformatics.

Bhupinder Singh Bhoop M Pharm, PhD, D St, is a Professor Pharmaceutics Pharmacokinetics at Univ Inst Pharm Sciences and Dean Alumni Panjab University Chandigarh India. He received awards like “Leading Educators of World” Cambridge “Shiksha Rattan Puruskar” India Int Soc “Best Indian Citizens Award” Int Pub House “Pharma Buzz Personality 2009” Founder Coordinator Student Research Convention Indian Universities’ Association. He has 107 peerreviewed publications and 4 Patents to his credit ScienceDirect declared his 2007 publication was among “Top 25 Articles”. He has guided/guiding 13 doctoral 47 postgraduate and 1 postdoctoral research projects and delivered 97 Invited Talks across the world including USA Canada Germany China. He is serving as an Editorial Board Member for 7 journals like Critical Rev Ther Drug Carrier Syst Indian, J Pharmacol Pharma Rev and Reviewer of 34 Journals including Clin Pharmacokinet, J Pharm Sci Pharm Res, AAPS, Pharm Sci Tech, J Pharm Pharmacol Eur, J PharmBiopharm, J Pharm BiomedAnal Int, J Pharm Drug DevInd Pharm etc.

Bolin Geng is a Principal Scientist and Project Chemistry Leader of Antibacterial IMED AstraZeneca plc. He received his PhD in organic chemistry from University of Montpellier II France in 1992. He has over 40 publications patents and patent application.

Jian Li is a Principal Scientist at the Monash Institute of Pharmaceutical Sciences Monash University in Melbourne Australia. He received his PhD in pharmaceutical sciences and microbiology from the University of South Australia 1999 to 2002 in Adelaide. He has an internationally recognized track record in pharmacokinetics and pharmacodynamics of polymyxins. He has published 55 papers in peerreviewed journals. Dr. Li is serving as an Associate Editor of BMC Microbiology and an editorial board member of another 3 journals. He is an invited reviewer for 31 international journals. His research is supported by Australian government eg National Health and Medical Research Council American National Institutes of Health NIH and pharmaceutical companies.

Taosheng Chen is a faculty member and Director of the High Throughput Screening Center at the Department of Chemical Biology and Therapeutics St Jude Childrens Research Hospital Memphis USA Prior to joining St Jude. He worked in the pharmaceutical industry BristolMyers Squibb for 6 years. He has received a PhD in Cell and Molecular Biology from the University of Vermont Burlington VT in 1996. He is serving as an editorial board member of 3 journals and Ad Hoc reviewer of 15 journals. He is also a grant reviewer for the NIH, MLSCN, HTS Assay Special Emphasis Panel. He has 33 peerreviewed publications.

Hu Yan is an Associate Professor of Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Japan. He has received a PhD in Engineering from University of Tokyo, Japan in 1992 to1995. He has completed his BS in Jilin University, China in 1978 to 1982. He is serving as an editorial board member of Recent Patents on Materials Science, Bentham Science Publishers Ltd, USA and reviewer of more than 6 journals. Publications: 8 books 69 papers and 31 patents; reviewer for: J Am Chem Soc Angew Chem Adv Mater Langmuir J Phys Chem Colloids and Surfaces A etc.

Sandeep Mukherjee is an Associate Professor of Internal Medicine Section of Gastroenterology and Hepatology University of Nebraska Medical Center UNCM Omaha Nebraska Staff Gastroenterologist Section of Gastroenterology Omaha Veterans Affairs Medical Center Omaha Nebraska. He received his medical degree MB;BCh from the University of Wales College of Medicine in 1991 and completed training in Internal Medicine Gastroenterology and Liver Transplantation in the United Kingdom and the United States. He has been on faculty at UNMC since 2000 and was Chief of the Section of Gastroenterology at Omaha VAMC from 2005 to 2008. He is on an editorial board member of 9 journals and reviewer of 13 journals. He has published 57 abstracts 72 peerreviewed articles authored or coauthored 4 book chapters and is the editor of the book Hepatitis C and Liver Transplantation.

Michael Retsky is Research Associate at Harvard School of Public Health Professor Adj at UANL Monterrey, Mexico, Member Manager at Electron Optics Development Co LLC www.eloptcom. He is a founder and on the Board of Directors of Colon Cancer Alliance www.ccallianceorg and Connecticut Optics and Photonics Association www.ctopaorg. He received a PhD in Physics from the University of Chicago in 1974. He is Guest Editor at the journal Cancers and has been Guest Editor at the journal Sensors and Algorithms. He reviews papers in a number of journals. He is CoPI of a 3year 600k cancer research grant from Komen Foundation. He has published over 50 papers in cancer research and physics.

Dr. Bhaswat S Chakraborty is currently 2005 to 2010 a Senior VP, Research Development of Cadila Pharmaceuticals Ltd, Ahmedabad, Gujarat, India where he is responsible for Clinical Pharmacology, Clinical Trials Ph IIV Bioequivalence Trials Preclinical Studies Bioinformatics and Data Management. He is also an Adjunct Faculty of Albany College of Pharmacy and Health Sciences, Albany, New York, USA; Editorial Board Member Journal of Bioequivalence Bioavailability; PhD Guide and External Examiner to a number of Universities in India. He has been a reviewer for several international journals and member of Ethics Committee and DSMB. Dr. Chakraborty received his PhD 1987 in Clinical Pharmacology from University of Sakatchewan Canada. He served as a Senior Safety and Efficacy Reviewer 1989 to 1997 and Acting Division Chief at the Therapeutic Drugs Directorate Canadian FDA Ottawa Canada. Dr. Chakraborty also served as the Director of Biopharmaceutics 1997 to 2000 Biovail Contract Research Toronto Canada and President of Foresee Consultant until the present assignment. He is founder of a Spiritual Association. Dr. Chakraborty has more than 60 research papers and abstracts in peer reviewed journals. He has received many merit awards and AAPS Visiting Scientist Awards.

Dr. Su Chen ,Chief Executive Officer at the Chainon Neurotrophin Biotechnolohy Inc, Texas, USA. Dr. Su Chen (Chief Executive Officer at the Chainon Neurotrophin Biotechnolohy Inc, Texas USA) got his PhD. in Mario Negri Institute for Pharmacological Research in Milan of Italy, and was a post doctoral research fellow in Italian National Research Council at Padova. After his research position as Senior Research Fellow at Department of Chemistry of the University of Warwick in UK, he joined in Department of Pharmacology at Rush University School of Medicine as assistant professor, and then Quest Diagnostic Nichols Institute as depatmental associate scientific director in the US. Dr. Chen has contributed significantly in areas of chemistry, biochemistry and pharmacology of marine phospholipids? particular in development of docosahexaenoic acid (DHA) - containing phospholipids for treatment of neurodegenerative disorders and infertility. He already published more than 44 articles and 3 book chapters in the field of lipids. Dr. Chen now is the Secretary-General of the International Society of Dietary Supplement and Phytotherapy from 2011 – 2014.

Michael Retsky is Research Associate at Harvard School of Public Health Professor, Adj at UANL Monterrey, Mexico, Member Manager at Electron Optics Development Co LLC www.eloptcom. He is a founder and on the Board of Directors of Colon Cancer Alliance www.ccallianceorg and Connecticut Optics and Photonics Association www.ctopaorg. He received a PhD in Physics from the University of Chicago in 1974. He is Guest Editor at the journal Cancers and has been Guest Editor at the journal Sensors and Algorithms. He reviews papers in a number of journals. He is CoPI of a 3year 600k cancer research grant from Komen Foundation. He has published over 50 papers in cancer research and physics.

Max K Leong Associate Professor, Department of Chemistry ,National Dong Hwa University, Taiwan, Adjunct Associate Professor, Department of Life Science and Institute of Biotechnology, National Dong Hwa University, Taiwan. He received his PhD in Chemical Physics from University of Texas at Austin and did his Post Doc in College of Pharmacy University of Texas at Austin. He worked for Division of Biotechnology and Pharmaceutical, Research National Health Research Institutes, Taiwan and TaiGen Biotechnology Ltd, Taiwan before he joined National Dong Hwa University. He served as the Associate Chief Editor of Chemistry The Chinese Chemistry Society Taipei in 2006 to 2007.

He earned his Ph.D. from University of Mumbai, India and Post-doctorate from Kyoto Pharmaceutical University, Japan. He has published and presented several original research papers, articles and abstracts in peer reviewed journals and conferences. He has conceptualized innovative drug delivery platform technologies and is an inventor in number of patents. He is an invited speaker at international scientific meetings and conferences. He serves as reviewer for more than 30 scientific international journals and is on Editorial/Advisory board of various journals.